"Prof Jacob George, who was appointed chief medical and scientific officer at the Medicines and Healthcare products Regulatory Agency (MHRA) in January, raised concerns that led to the Pathways trial being put on hold by the government, according to the Sunday Times. But the regulator announced on Saturday that George would recuse himself from involvement in the trial after gender-critical social media posts made last year emerged."
"The Pathways trial, which was intended to assess the effect of puberty blockers on children questioning their gender identity, was due to begin recruiting participants in January. But it was paused in February after the medicines regulator raised concerns over the wellbeing of children and young people taking part."
"However, the regulator has now said the minimum age limit should be 14 because of the unquantified risk of long-term biological harms. The clinical trial had planned to recruit an estimated 226 young people over the next three years."
Prof Jacob George, chief medical and scientific officer at the MHRA, was removed from involvement in the Pathways trial after gender-critical social media posts emerged. The trial, designed to assess puberty blockers' effects on children questioning their gender identity, was paused in February following regulatory concerns about child wellbeing. The MHRA raised the minimum age requirement from 10-12 years to 14 years due to unquantified risks of long-term biological harms. The trial planned to recruit approximately 226 young people over three years and followed recommendations from the Cass review into children's gender care, which questioned the quality of research supporting such medication.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]